Sort
39,280 grants matching “leukemia”
Mapping and targeting 3D regulatory elements in leukemia and lymphoma
$690,772Iannis Aifantis · New York University School Of Medicine · R01 · FY2025 · CA
Regulation of hematopoiesis by ribosomal protein paralogs
$690,669David L Wiest · Research Inst Of Fox Chase Can Ctr · R37 · FY2025 · AI
FUNCTION OF LACTOSAMINYL GLYCANS IN EARLY HEMATOPOIETIC AND MYELOPOIETIC CELLS
$690,663Robert Sackstein · Brigham And Women'S Hospital · P01 · FY2014 · HL
Geospatially modeled environmental risk factors for lymphoid malignancies
$690,548Brenda M Birmann · Brigham And Women'S Hospital · R01 · FY2025 · ES
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
$690,485Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Brain Tumors - Immunological and Biological Studies
$690,468Darell D Bigner · Duke University · R37 · FY2009 · CA
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
$690,281Melissa A. Simon · Ecog-Acrin Medical Research Foundation · U01 · FY2023 · CA
Neural Phenotypes of Females with Autism Spectrum Disorder
$690,279Christine Wu Nordahl · University Of California At Davis · R01 · FY2014 · MH
Development of a Universal Assay for Minimal Residual Disease in Acute Myeloid Leukemia using Duplex Sequencing
$690,175Jesse J Salk · Twinstrand Biosciences, Inc. · R44 · FY2019 · CA
Development of a Universal Assay for Minimal Residual Disease in Acute Myeloid Leukemia using Duplex Sequencing
$690,175Jesse J Salk · Twinstrand Biosciences, Inc. · R44 · FY2020 · CA
Targeting obesity to improve survival from childhood acute lymphoblastic leukemia
$690,162Etan Orgel · Children'S Hospital Of Los Angeles · R37 · FY2022 · CA
Mechanisms and therapeutic implications of human clonal hematopoiesis (CH) mutations
$689,125Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
Novel targeted therapy for treating Ovarian Cancer
$689,000Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2022 · CA
Mechanisms of RUNX1 transcriptional control in hematopoiesis
$688,800Kristy Stengel · Albert Einstein College Of Medicine · R01 · FY2024 · HL
Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes
$688,759Christopher Y Park · New York University School Of Medicine · R01 · FY2022 · CA
Establishing Mixed Hematopoietic Chimerism in a Canine Model
$688,758Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2011 · CA
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
$688,740Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Modulate Cullin-RING E3 ubiquitin ligases by small molecule agents
$688,716Zhen-Qiang Pan · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Modulate Cullin-RING E3 ubiquitin ligases by small molecule agents
$688,716Zhen-Qiang Pan · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome
$688,546Katharine C Hsu · Sloan-Kettering Inst Can Research · R01 · FY2025 · AI
Novel patient biomarkers and mechanisms of TKI associated Cardiotoxicity
$688,364Daniel Addison · Ohio State University · R01 · FY2024 · HL
Gene Regulation In The Immune System
$688,320Keiko Ozato · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD
Rochester Network Lead Academic Participating Site
$688,151Paul M Barr · University Of Rochester · UG1 · FY2023 · CA
Using mouse models to probe the relationship of oncogenesis to development and o
$688,149Eric C Holland · Sloan-Kettering Inst Can Research · U01 · FY2010 · CA
Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia
$687,979Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA